Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1401)

Milan, Lombardy 20133

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Small Cell Lung Carcinoma

Studies at this site

• A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) — Running, not enrolling
• Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008) — Running, not enrolling